Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Stuart, J.a; b; * | Ellory, J.C.a; b | Stone, P.C.W.a; b
Affiliations: [a] Department of Haematology, Medical School, University of Birmingham, Birmingham B15 2TJ, UK | [b] Department of Physiology, University of Oxford, Oxford OX1 3PT, UK
Correspondence: [*] Correspondence to: Professor J. Stuart, Birmingham.
Note: [] Accepted by: Editor M.R. Boisseau
Abstract: Bepridil is a new calcium antagonist that was found to cause swelling and stomatocytosis of normal erythrocytes by increasing passive permeability of cations across the cell membrane. At 100 µmol/l, the drug also fully inhibited the Ca2+-activated (Gardos) K+ channel. When normal and sickle erythrocytes were dehydrated by Ca2+ loading using the ionophore A23187, bepridil at 10–100 µmol/l had a significant protective effect against loss of filterability through pores of 5 µm diameter. Bepridil has the potential to prevent erythrocyte dehydration and sickling by blocking entry of Ca2+, by inhibiting loss of K+ via the Gardos channel, and by increasing passive permeability of cations from plasma.
Keywords: Rheology, Erythrocyte deformability, Sickle cell anemia
DOI: 10.3233/CH-1989-9207
Journal: Clinical Hemorheology and Microcirculation, vol. 9, no. 2, pp. 247-255, 1989
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]